
Next-Generation Cancer Drug Found To Slow Aging and Boost Longevity in Lab Study – SciTechDaily
A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop. Researchers at Queen Mary University of Londons School of Biological and Behavioural Sciences have found that the new TOR inhibitor rapalink-1 can extend the chronological lifespan o…
Source: SciTechDaily
Read More








